GratXray was founded July 7th 2017, as a spin-off company of the ETH Zürich and the Paul Scherrer Institute.

GratXray is a new company that will bring grating interferometry based phase contrast imaging from lab to clinics. The first application will be in the field of breast cancer imaging, where we will build a dedicated breast computed tomography system for the painless, efficient and precise imaging of the female breast.

The company was founded by Prof. Dr. Marco Stampanoni, Dr. Zhentian Wang, Dr. Martin Stauber, Martin Jermann and the Paul Scherrer Institute.

 

 

<- back

GratXray is supported by